Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers

Completed · Phase 2

Conditions studied: Circadian Rhythm Sleep Disorders

In brief

The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.

Key facts

Study ID

NCT00490945

Run by

Vanda Pharmaceuticals

People needed

45

Starts

2004-07-01

Expected to finish

2005-03-01

Last updated by the study team

2014-08-26

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No medical, psychiatric, or sleep disorders
• Ability to provide written informed consent

You may not qualify if…

• Lifetime history of night shift work
• Evidence of any sleep disorder
• Psychiatric or neurological disorders

Where it is running

• Vanda Investigational Site — Boston, Massachusetts, United States
• Vanda Investigational Site — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.